Navigation Links
Ductal lavage may detect early breast cancer

At times when the breast lumps are too small to be picked up by a mammogram, the patient may be unaware that she is a potential candidate for breast cancer. But to offset this problem, scientists at the Johns Hopkins University School of Medicine, Baltimore headed by Dr. Saraswathi Sukumar, have devised a new method of detecting early stages of breast cancer by using a new method called ductal lavage. Ductal lavage, involves "washing" breast milk ducts with saline and examining cells for signs of precancerous or cancerous changes.

Sukumar's team examined samples of ductal fluid from women with breast cancer and women without the disease to detect signs of a process called methylation.

The presence of markers for this process suggests that a woman has breast cancer or precancerous breast cells, according to her. Ductal lavage is a "very sensitive, relatively simple test," according to Sukumar.

The procedure, which takes about half an hour to perform, eventually may become a part of routine breast cancer screening, she said. Ductal lavage "would be a great tool for assessing risk," according to Sukumar.

If the lavage detected precancerous cells, a woman could be followed more closely to see whether she developed cancer, Sukumar explained. Based on the test, women might be treated with drugs shown to prevent breast cancer.
'"/>




Page: 1

Related medicine news :

1. Correlation Between Bile Duct Obstruction and Ductal Cancer Found
2. Vitamin B12 can help in detecting cancers
3. “Brain fingerprinting”- The new lie detectr
4. Better prostate cancer detection
5. Early detection of prostate cancer
6. Early detection of heart attack
7. Cytobrush to detect oral cancer
8. New device for detecting artery blockages
9. Prototype Detector detects Anthrax Quickly
10. Schizophrenia detected early
11. Computer Program can assist to detect Heart Attack
Post Your Comments:
(Date:5/16/2008)...hy Back Acquires Rival JoAnne,s Bed & Back; Merger... Company Owned Back Retail Chain, LORTON, Va., Ma...,company whose focus on home and workplace back we...ed all substantial assets of its rival,JoAnne,s B...division,claimed 2007 revenues of $40million. JoAn...
(Date:5/16/2008)NEW YORK, May 16 /PRNewswire/ -- There,s more to a healthy mouth than,flashing a set of pearly whites. Here,s the scoop on America,s oral care,habits - and what it means for our overall health.,
(Date:5/16/2008)...rs could report side effects, but critics want age...ay 16 (HealthDay News) -- Direct-to-consumer drug ... number that would allow consumers to report adver...day. , The experts serve on a panel that advise...e numbers are already mandated by the FDA for prin...
(Date:5/16/2008)...long Campaign to Emphasize the Importance of Oral ...wswire/ -- National dental insurer United,Concordi...llaboration,between Oral Health America and the Br...rtance of oral health to overall health. Beginning...ted States for the first time,making it the large...
Breaking Medicine News(10 mins):Health News:The Back Wars Come to a Close 2Health News:FDA Panel Considers Toll-Free Number for TV Drug Ads 2Health News:FDA Panel Considers Toll-Free Number for TV Drug Ads 3Health News:United Concordia Dental Celebrates National Smile Month 2
...essfully performed on an eight-month-old Egyptian ...m Ibrahim was initially evaluated by a team of pae...l and was diagnosed to have complete atrio-ventric...s -- a condition wherein there are holes in the up...
...itiated a two-year study to measure the wellbeing ...nce with respect to// schooling, education and oth...ble impact on childhood, will be studied, to ascer...tiative is headed by Prof Richard Layard, a former...
...hird of the country's children in a five-year prog...n children in 1,301 counties of central and wester...inst hepatitis B, said Jiang Zuojun, the Vice-Mini...th officials will have to quicken their pace to re...
...re suffering due to cuts in NHS expenditure, as co...y says.// The study, which has been commissioned...ered that almost seven out of 10 local authorities...it, have suffered. Cost-cutting measures of the N...
Other Medicine News:
(Date:5/16/2008)... Highlights Include:, -- Results demonstrating ... clinically meaningful extension of progression-fr...zumab to attack both the inside and,outside of the...ckade, -- Data demonstrating activity of TYKERB a...tiple lines of trastuzumab and chemotherapy, LOND...
(Date:5/16/2008)... - ANX-530 Demonstrates Statistically Significant ...fety Observations, - Abstract to be published in 2... Clinical Oncology, SAN DIEGO, ...uticals,Inc. (Amex: ANX ) announced today that, ... ANX-530 demonstrated a statistically significant ...
(Date:5/15/2008)... - First in human clinical data highlight safety ...h advanced solid tumors -, BRISBANE, Calif., May ...ly held biopharmaceutical company developing novel...rting its lead PARP inhibitor, BSI-201, will,be pr...ncology annual,meeting in Chicago., Findings will...
(Date:5/15/2008)... KENILWORTH, N.J., May 15 /PRNewswire-FirstCall/...eader in advancing the science and treatment of,ch... today that data from,several clinical studies wit...L(R) (ribavirin, USP) combination therapy, as well... HCV protease inhibitor, will be presented at,the ...
Breaking Medicine Technology:GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 2GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 3GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 4GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 5GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 6GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 7ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 2ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 3ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 4ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 5BiPar Sciences Announces Clinical Data Presentations on Lead PARP Inhibitor, BSI-201, at 40th American Society of Clinical Oncology Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 3Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 4Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 6Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 7Family history of alcoholism affects response to drug used to treat heavy drinking 1563 1Family history of alcoholism affects response to drug used to treat heavy drinking 1563 2New study shows fish respond quickly to changes in mercury deposition 452 1New study shows fish respond quickly to changes in mercury deposition 452 2New study shows fish respond quickly to changes in mercury deposition 452 3 3Ci 3ECosby 3C i 3E Star Tackles a Silent Heart Threat 1557 1 3Ci 3ECosby 3C i 3E Star Tackles a Silent Heart Threat 1557 2 3Ci 3ECosby 3C i 3E Star Tackles a Silent Heart Threat 1557 3 3Ci 3ECosby 3C i 3E Star Tackles a Silent Heart Threat 1557 4IsoTis Integra Merger 678 1IsoTis Integra Merger 678 2IsoTis Integra Merger 678 3IsoTis Integra Merger 678 4IsoTis Integra Merger 678 5
...RN, Pa.--(BUSINESS WIRE)--Mar 7, 2007 - Gemin X,an...e version of,the journal Blood demonstrated that i...tent cytotoxic responses against,patient-derived m...,enhanced anti-myeloma effects when used as a comb...ifically designed to inhibit all,relevant members ...
...NESS WIRE)--Mar 7, 2007 - Advanced Viral,Research ...cal,company, announced today that new information ... 2007 Proceedings of the American,Society of Clini...lication will be distributed to the nearly 25,000 ...ar,s meeting in Chicago on,June 1-5., Based on rec...
Other Medicine Technology:Gemin X Announces Publication of Preclinical Data of GX15-070 in,Multiple Myeloma in Blood 2American Society of Clinical Oncology (ASCO) Accepts New Data on,AVR118 for Publication in 2007 Abstract Book 2American Society of Clinical Oncology (ASCO) Accepts New Data on,AVR118 for Publication in 2007 Abstract Book 3
Clearview C. Diff A is a one-step test for the direct qualitative detection of Clostridium difficile toxin A from fecal samples.
ThyroTest TSH is a rapid, qualitative test for hypothyroidism screening in adults.
...is one of the easiest tests to run on the market t...th no hands-on time. Critical care instructions ca...g the pediatrician's office and valuable informati...help control the spread of RSV infections. Now the...
The BinaxNOW Influenza A & B Test simplifies rapid influenza testing. The easiest flu test on the market just got easier with accurate differentiation between influenza A and influenza B using one si
Medicine Products: